Russian laboratory to give cancer vaccine to first patients soon

Published at: 03/08/2025 06:20 PM

The director of the Gamaleya Russian Epidemiology and Microbiology Research Center, Alexander Guintsburg, announced that the first patients will soon begin to receive treatment with a personalized Russian cancer vaccine.

Speaking to RIA Novosti, this Sunday, the scientist explained that, “according to the current plan, agreed with the Ministry of Health, we should start administering a neoantigen-based cancer vaccine to a group of patients with melanoma on an experimental basis in the coming months.”

He stressed that this work will be carried out by the Guerzen Oncological Research Institute in Moscow and the Blokhín National Oncological Medical Research Center, since Gamaleya is only involved in the production of vaccines.

Guíntsburg added that the drug is created based on the personal genetic data of a specific patient and can only be used on that person and “on no one else”, so the Government issued a corresponding decree earlier this year. “And there are completely different regulations (on the use of the vaccine), which are being applied for the first time. However, we found a common language, a common denominator, and we moved forward.”

In addition, he revealed that the new vaccine generates interest in other countries that write letters to him about it.

Mazo News Team